Guard Therapeutics a annoncé que les résultats préliminaires de son étude de phase 2b POINTER, menée avec le candidat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback